| 臺大學術典藏 |
2021-01-06T03:58:30Z |
High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: A prospective observational study in Taiwan
|
JIH-LUH TANG; Kung H.-C.; Lei W.-C.; Yao M.; Wu U.-I.; Hsu S.-C.; Lin C.-T.; Li C.-C.; Wu S.-J.; Hou H.-A.; Chou W.-C.; Huang S.-Y.; Tsay W.; Chen Y.-C.; Chen Y.-C.; Chang S.-C.; Ko B.-S.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:30Z |
TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution
|
Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Lin L.-I.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:30Z |
High risk of hepatitis B reactivation among patients with acute myeloid leukemia
|
Chen C.-Y.; Huang S.-Y.; Cheng A.; Chou W.-C.; Yao M.; JIH-LUH TANG; Tsay W.; Sheng W.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:29Z |
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
|
JIH-LUH TANG; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.; Liu C.-W.; Chiang Y.-C.; Liu M.-C.; Huang C.-F.; Tseng M.-H.; Lin L.-I.; Chen C.-Y.; Hou H.-A.; Lin Y.-C.; Kuo Y.-Y.; Chou W.-C.; Lin C.-C.; Liu C.-Y. |
| 臺大學術典藏 |
2021-01-06T03:58:29Z |
Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective study
|
Huang S.-Y.; Lin H.-H.; Yao M.; JIH-LUH TANG; Wu S.-J.; Hou H.-A.; Chou W.-C.; Chou S.-C.; Hsu S.-C.; Ko B.-S.; Lu H.-Y.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:28Z |
Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma
|
Huang S.-Y.; Lin H.-H.; Lin C.-W.; Li C.-C.; Yao M.; JIH-LUH TANG; Hou H.-A.; Tsay W.; Chou S.-J.; Cheng C.-L.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:28Z |
Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)
|
Liu C.-Y.; Tien H.-F.; Yao C.-Y.; Hou H.-A.; Lin T.-Y.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Kuo Y.-Y.; Wu S.-J.; Liao X.-W.; Lin C.-T.; Ko B.-S.; Chen C.-Y.; Hsu S.-C.; Li C.-C.; Huang S.-Y.; Yao M.; JIH-LUH TANG; Tsay W. |
| 臺大學術典藏 |
2021-01-06T03:58:28Z |
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
|
Hou H.-A.; Liu C.-Y.; Kuo Y.-Y.; Chou W.-C.; Tsai C.-H.; Lin C.-C.; Lin L.-I.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG; Yao M.; Li C.-C.; Huang S.Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:27Z |
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
|
Tsai C.-H.; Hou H.-A.; JIH-LUH TANG; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Kuo Y.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Tsay W.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:27Z |
Clinical outcomes of primary intraocular lymphoma patients treated with front-line systemic high-dose methotrexate and intravitreal methotrexate injection
|
Ma W.-L.; Hou H.-A.; Hsu Y.-J.; Chen Y.-K.; JIH-LUH TANG; Tsay W.; Yeh P.-T.; Yang C.-M.; Lin C.-P.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:26Z |
Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008–2013
|
Chen C.-Y.; Tien F.-M.; Sheng W.-H.; Huang S.-Y.; Yao M.; JIH-LUH TANG; Tsay W.; Tien H.-F.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-06T03:58:26Z |
Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas
|
Wang Y.-C.; Kuo S.-H.; Cheng A.-L.; Ma W.-L.; Yao M.; Liao S.-L.; JIH-LUH TANG |
| 臺大學術典藏 |
2021-01-06T03:58:26Z |
Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma
|
Wang C.-W.; Hong R.-L.; Tsai C.-L.; Yao M.; JIH-LUH TANG; Lin C.-W.; Cheng A.-L.; Kuo S.-H.; Yang C.W.-C. |
| 臺大學術典藏 |
2021-01-06T03:58:26Z |
Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation
|
Chiang Y.; Tsai C.-H.; Kuo S.-H.; Liu C.-Y.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Lin C.-T.; Hou H.-A.; Chou W.-C.; Liu J.-H.; Lin C.-C.; Wu S.-J.; Hsu S.-C.; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Chou H.-T.; Lu M.-Y.; Yang Y.-L.; Chang H.-H.; Liu M.-C.; Liao X.-W.; Wu J.-K.; Chou S.-C.; Cheng C.-L.; Chen C.-Y.; Tsay W.; Tien H.-F.; JIH-LUH TANG; Chen Y.-H. |
| 臺大學術典藏 |
2021-01-06T03:58:25Z |
Reactive Follicular Hyperplasia With Perifollicular Granulomas and Increased IgG4-Positive Plasma Cells
|
Yu S.-C.; JIH-LUH TANG |
| 臺大學術典藏 |
2021-01-06T03:58:25Z |
Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia
|
Hou H.-A.; Lu J.-W.; Lin T.-Y.; Tsai C.-H.; Chou W.-C.; Lin C.-C.; Kuo Y.-Y.; Liu C.-Y.; Tseng M.-H.; Chiang Y.-C.; Peng Y.-L.; JIH-LUH TANG; Gong Z.; Lin L.-I.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:25Z |
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
|
Tsai C.-H.; Hou H.-A.; JIH-LUH TANG; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Liu C.-Y.; Tseng M.-H.; Lin T.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Lin C.-T.; Wu S.-J.; Chen C.-Y.; Tsay W.; Chuang E.Y.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:25Z |
Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase
|
Yu S.-C.; Huang H.-H.; Li C.-C.; JIH-LUH TANG; Lee Y.-H.; Mao T.-L.; Kuo K.-T.; Lin C.-T.; Liu J.-H.; Ko B.-S.; Yao M. |
| 臺大學術典藏 |
2021-01-06T03:58:24Z |
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome
|
Hou H.-A.; Tsai C.-H.; Lin C.-C.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Yao M.; JIH-LUH TANG; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:24Z |
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
|
Chen C.-Y.; Tien F.-M.; Cheng A.; Huang S.-Y.; Chou W.-C.; Yao M.; JIH-LUH TANG; Tien H.-F.; Sheng W.-H. |
| 臺大學術典藏 |
2021-01-06T03:58:24Z |
Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
|
Lin M.-E.; Hou H.-A.; Tsai C.-H.; Wu S.-J.; Kuo Y.-Y.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Chou W.-C.; Chen C.-Y.; JIH-LUH TANG; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Lin C.-T.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:23Z |
Retrospective analysis of frontline treatment efficacy in elderly patients with diffuse large B-cell lymphoma
|
Cheng C.-L.; Liu J.-H.; Chou S.-C.; Yao M.; JIH-LUH TANG; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:23Z |
Stem cell transplantation for T-cell lymphomas in Taiwan
|
Hsu Y.-T.; Tsai H.-J.; Chang J.S.; Li S.-S.; JIH-LUH TANG; Yeh S.-P.; Hwang W.-L.; Liu J.-H.; Tan T.-D.; Wang P.-N.; Hsiao H.-H.; Chen T.-Y. |
| 臺大學術典藏 |
2021-01-06T03:58:23Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
Tien F.-M.; Hou H.-A.; Tsai C.-H.; JIH-LUH TANG; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:22Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
Tien F.-M.; Hou H.-A.; Tsai C.-H.; JIH-LUH TANG; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Yao M.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:22Z |
Mayo Alliance Prognostic Model for Myelodysplastic Syndromes: Integration of Genetic and Clinical Information
|
Tefferi A.; Gangat N.; Mudireddy M.; Lasho T.L.; Finke C.; Begna K.H.; Elliott M.A.; Al-Kali A.; Litzow M.R.; Hook C.C.; Wolanskyj A.P.; Hogan W.J.; Patnaik M.M.; Pardanani A.; Zblewski D.L.; He R.; Viswanatha D.; Hanson C.A.; Ketterling R.P.; JIH-LUH TANG; Chou W.-C.; Lin C.-C.; Tsai C.-H.; Tien H.-F.; Hou H.-A. |
| 臺大學術典藏 |
2021-01-06T03:58:22Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; JIH-LUH TANG; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:21Z |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Lin C.-T.; Hsueh P.-R.; Wu S.-J.; Yao M.; Ko B.-S.; Li C.-C.; Hsu C.-A.; JIH-LUH TANG; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:21Z |
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
|
Ko B.-S.; Wang Y.-F.; Li J.-L.; Li C.-C.; Weng P.-F.; Hsu S.-C.; Hou H.-A.; Huang H.-H.; Yao M.; Lin C.-T.; Liu J.-H.; Tsai C.-H.; Huang T.-C.; Wu S.-J.; Huang S.-Y.; Chou W.-C.; Tien H.-F.; Lee C.-C.; JIH-LUH TANG |
| 臺大學術典藏 |
2021-01-06T03:58:21Z |
Clonal sequence tracking reveals TET2-mutated extranodal NK/T-cell lymphoma disseminated independent of Epstein Barr virus
|
Yuan C.-T.; Huang T.-C.; Chuang C.-C.; Chuang Y.-K.; Tsai J.-H.; Liau J.-Y.; Lin C.-W.; JIH-LUH TANG |
| 臺大學術典藏 |
2021-01-06T03:58:20Z |
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): An international study on 331 patients
|
Christen F.; Hoyer K.; Yoshida K.; Hou H.-A.; Waldhueter N.; Heuser M.; Hills R.K.; Chan W.; Hablesreiter R.; Blau O.; Ochi Y.; Klement P.; Chou W.-C.; Blau I.-W.; JIH-LUH TANG; Zemojtel T.; Shiraishi Y.; Shiozawa Y.; Thol F.; Ganser A.; Löwenberg B.; Linch D.C.; Bullinger L.; Valk P.J.M.; Tien H.-F.; Gale R.E.; Ogawa S.; Damm F. |
| 臺大學術典藏 |
2021-01-06T03:58:20Z |
A phase IV, randomized, multicenter, open-label trial comparing efficacy and systemic exposure for a standard weight-based dose versus a fixed dose of plerixafor in combination with G-CSF in patients with Non-Hodgkin’s lymphoma weighing ≤70 kg
|
Kuruvilla J.; Tzeng C.-H.; Cho S.-G.; Kim S.J.; JIH-LUH TANG; Su Y.; Wu J.; Vargo R.; Cheverton P. |
| 臺大學術典藏 |
2021-01-06T03:58:20Z |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Tsai C.-H.; Yao C.-Y.; Tien F.-M.; JIH-LUH TANG; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:19Z |
Learning a Cytometric Deep Phenotype Embedding for Automatic Hematological Malignancies Classification
|
Li J.-L.; Wang Y.-F.; Ko B.-S.; Li C.-C.; JIH-LUH TANG; Lee C.-C. |
| 臺大學術典藏 |
2021-01-06T03:58:19Z |
A BLSTM with Attention Network for Predicting Acute Myeloid Leukemia Patient's Prognosis using Comprehensive Clinical Parameters
|
Lu C.-C.; Li J.-L.; Wang Y.-F.; Ko B.-S.; JIH-LUH TANG; Lee C.-C. |
| 臺大學術典藏 |
2021-01-06T03:58:19Z |
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
|
Huang H.-H.; Chen F.-Y.; Chou W.-C.; Hou H.-A.; Ko B.-S.; Lin C.-T.; JIH-LUH TANG; Li C.-C.; Yao M.; Tsay W.; Hsu S.-C.; Wu S.-J.; Chen C.-Y.; Huang S.-Y.; Tseng M.-H.; Tien H.-F.; Chen R.-H. |
| 臺大學術典藏 |
2021-01-06T03:58:19Z |
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study
|
Liu J.-H.; Liao X.-W.; Chen C.-H.; Yao M.; Li C.-C.; Lin C.-T.; Tsai C.-H.; Chou W.-C.; Hou H.-A.; Huang S.-Y.; Wu S.-J.; Chen Y.-C.; Tien H.-F.; JIH-LUH TANG; Ko B.-S. |
| 臺大學術典藏 |
2021-01-06T03:58:18Z |
Phase 2 study of anti-human cytomegalovirus monoclonal antibodies for prophylaxis in hematopoietic cell transplantation
|
Maertens J.; Logan A.C.; Jang J.; Long G.; JIH-LUH TANG; Hwang W.Y.K.; Koh L.P.; Chemaly R.; Gerbitz A.; Winkler J.; Yeh S.-P.; Hiemenz J.; Christoph S.; Lee D.-G.; Wang P.-N.; Holler E.; Mielke S.; Akard L.; Yeo A.; Ramachandra S.; Smith K.; Pertel P.; Segal F. |
| 臺大學術典藏 |
2021-01-06T03:58:18Z |
Advances in hematopoietic stem cell transplantation in the Asia-Pacific region: the second report from APBMT 2005–2015
|
Kang H.J.; Ong T.C.; Gyi A.A.; Farzana T.; Baylon H.; Gooneratne L.; JIH-LUH TANG; Bunworasate U.; Huynh V.M.; Srivastava A.; Okamoto S.; Atsuta Y.; Registry Committee of the Asia-Pacific Blood; Marrow Transplantation Group (APBMT); Iida M.; Kodera Y.; Dodds A.; Ho A.Y.L.; Nivison-Smith I.; Akter M.R.; Wu T.; Lie A.K.W.; Ghavamzadeh A. |
| 臺大學術典藏 |
2021-01-06T03:58:17Z |
Clinical characteristics and treatment outcomes of pulmonary invasive fungal infection among adult patients with hematological malignancy in a medical centre in Taiwan, 2008–2013
|
Chen C.-Y.; Sheng W.-H.; Tien F.-M.; Lee P.-C.; Huang S.-Y.; JIH-LUH TANG; Tsay W.; Tien H.-F.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-06T03:58:17Z |
Correlative analysis of overall survival with clinical characteristics in 127 patients with mantle cell lymphoma: a multi-institutional cohort in Taiwan
|
Wang Y.-H.; Yu S.-C.; Ko B.-S.; Yang Y.-T.; Yao M.; JIH-LUH TANG; Huang T.-C. |
| 臺大學術典藏 |
2021-01-06T03:58:17Z |
A Knowledge-Reserved Distillation with Complementary Transfer for Automated FC-based Classification Across Hematological Malignancies
|
Li J.-L.; Chang T.-Y.; Wang Y.-F.; Ko B.-S.; JIH-LUH TANG; Lee C.-C. |
| 臺大學術典藏 |
2021-01-06T03:58:17Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; Tien F.-M.; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; JIH-LUH TANG; Chou W.-C.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:16Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; Tien F.-M.; Chou W.-C.; JIH-LUH TANG; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:16Z |
Comparison of clinicopathological features and treatment outcomes in aggressive primary intestinal B- and T/NK-cell lymphomas
|
Cheng A.-L.; Kuo S.-H.; Yeh Y.-C.; Wang H.-P.; Wang Y.-T.; Lin C.-W.; JIH-LUH TANG; Yao M.; Yeh K.-H.; Ma W.-L. |
| 臺大學術典藏 |
2020-10-28T02:42:55Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang, Yu-Hung; JIH-LUH TANG; Lee, Sze-Hwei; CHENG-HONG TSAI; Wu, Shan-Ju; HSIN-AN HOU; TAI-CHUNG HUANG; YUAN-YEH KUO; MING YAO; Chang, Koping; CHUNG-WU LIN; Lin, Yun-Chu; Tien, Fen-Ming; Chou, Wen-Chien; HWEI-FANG TIEN; CHIEN-CHIN LIN |
| 臺大學術典藏 |
2020 |
Correlative analysis of overall survival with clinical characteristics in 127 patients with mantle cell lymphoma: a multi-institutional cohort in Taiwan
|
Yu-Hung Wang; SHAN-CHI YU; BOR-SHENG KO; YI-TSUNG YANG; MING YAO; JIH-LUH TANG; Tai-Chung Huang |
| 臺大學術典藏 |
2018-09-10T18:03:09Z |
2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan
|
Ko, B.-S. and Chen, W.-T. and Kung, H.-C. and Wu, U.-I. and Tang, J.-L. and Yao, M. and Chen, Y.-C. and Tien, H.-F. and Chang, S.-C. and Chuang, Y.-C. and Lin, D.-T.; HWEI-FANG TIEN; UN-IN WU; JIH-LUH TANG; BOR-SHENG KO; SHAN-CHWEN CHANG; YEE-CHUN CHEN; MING YAO |
| 臺大學術典藏 |
2018-09-10T18:03:05Z |
Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma
|
Yang, C.W.-C. and Wang, C.-W. and Hong, R.-L. and Tsai, C.-L. and Yao, M. and Tang, J.-L. and Lin, C.-W. and Cheng, A.-L. and Kuo, S.-H.; CHUNG-WU LIN; JIH-LUH TANG; ANN-LII CHENG; MING YAO |
| 臺大學術典藏 |
2018-09-10T18:01:22Z |
Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008�V2013
|
Chen, C.-Y. and Tien, F.-M. and Sheng, W.-H. and Huang, S.-Y. and Yao, M. and Tang, J.-L. and Tsay, W. and Tien, H.-F. and Hsueh, P.-R.; PO-REN HSUEH; HWEI-FANG TIEN; WANG-HUEI SHENG; JIH-LUH TANG; MING YAO; SHANG-YI HUANG |
